Manulife (Manufacturers Life Insurance)
ZNTL icon

Manulife (Manufacturers Life Insurance)’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22,874
Closed -$36.4K – 3014
2025
Q1 		$36.4K Sell
22,874
-105,334
-82% -$227K ﹤0.01% 2858
2024
Q4 		$388K Buy
128,208
+84
+0.1% +$275 ﹤0.01% 2354
2024
Q3 		$471K Sell
128,124
-1,005
-0.8% -$3.65K ﹤0.01% 2318
2024
Q2 		$528K Sell
129,129
-2,686
-2% -$30K ﹤0.01% 2195
2024
Q1 		$2.08M Buy
131,815
+14,921
+13% +$205K ﹤0.01% 1503
2023
Q4 		$1.77M Buy
116,894
+26,491
+29% +$386K ﹤0.01% 1510
2023
Q3 		$1.81M Buy
90,403
+8,783
+11% +$223K ﹤0.01% 1472
2023
Q2 		$2.3M Buy
81,620
+18,501
+29% +$444K ﹤0.01% 1375
2023
Q1 		$1.09M Buy
63,119
+33
+0.1% +$668 ﹤0.01% 1595
2022
Q4 		$1.19M Buy
63,086
+3,526
+6% +$75.8K ﹤0.01% 1537
2022
Q3 		$1.28M Sell
59,560
-302
-0.5% -$8.26K ﹤0.01% 1505
2022
Q2 		$1.64M Sell
59,862
-9,951
-14% -$264K ﹤0.01% 1471
2022
Q1 		$3.19M Buy
69,813
+51,392
+279% +$2.77M ﹤0.01% 1384
2021
Q4 		$1.53K Buy
18,421
+181
+1% +$14K ﹤0.01% 1607
2021
Q3 		$1.22M Sell
18,240
-325
-2% -$18.7K ﹤0.01% 1718
2021
Q2 		$988K Buy
18,565
+2,399
+15% +$128K ﹤0.01% 2003
2021
Q1 		$701K Sell
16,166
-796
-5% -$34.3K ﹤0.01% 2080
2020
Q4 		$881K Buy
16,962
+10,625
+168% +$479K ﹤0.01% 1892
2020
Q3 		$207K Buy
6,337
+402
+7% +$14.1K ﹤0.01% 2542
2020
Q2 		$270K Buy
+5,935
New +$228K ﹤0.01% 2321

Other funds holding ZNTL

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ZNTL Position: Q2 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of Zentalis Pharmaceuticals (ZNTL) in Q2 2025, closing a stake of 22,874 shares — an estimated $36.4K sold.

Manulife (Manufacturers Life Insurance) first reported a position in ZNTL in Q2 2020 and held it in 20 quarters. The position peaked at $3.19M in Q1 2022. 117 funds tracked by Wall St. Rank hold ZNTL as of Q2 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining Zentalis Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 22,874 Zentalis Pharmaceuticals shares in Q2 2025, an estimated $36.4K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Zentalis Pharmaceuticals in Q2 2020 and held it in 20 quarters.
  • Manulife (Manufacturers Life Insurance)'s Zentalis Pharmaceuticals position peaked at $3.19M in Q1 2022.
  • 117 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q2 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2025, filed 14 Aug 2025.